Achieve Life Sciences (ACHV) News Today $2.44 -0.01 (-0.41%) Closing price 04:00 PM EasternExtended Trading$2.49 +0.05 (+2.05%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACHV Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Achieve Life Sciences (NASDAQ:ACHV) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPSAugust 10 at 5:53 PM | marketbeat.comACHV: Second Quarter ResultsAugust 8, 2025 | msn.comAchieve (ACHV) Q2 Net Loss Hits $12.7MAugust 7, 2025 | fool.comAchieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline ProgramAugust 7, 2025 | globenewswire.comAchieve Life Sciences Q2 2025 Earnings PreviewAugust 6, 2025 | msn.comAchieve Life Sciences (ACHV) Projected to Post Earnings on ThursdayJuly 31, 2025 | marketbeat.comAchieve Life Sciences to Participate in the BTIG Virtual Biotechnology ConferenceJuly 29, 2025 | globenewswire.comAchieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025July 24, 2025 | globenewswire.comShould You Hold Achieve Life Sciences (ACHV)? - Insider MonkeyJuly 8, 2025 | insidermonkey.comAchieve Life Sciences: Nearing Commercialization Of A Best-In-Class Pharmaceutical Product For Smoking CessationJuly 7, 2025 | seekingalpha.comAchieve Life Sciences, Inc. (ACHV) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comAchieve Life Sciences (ACHV) Receives a Buy from Raymond JamesJuly 4, 2025 | theglobeandmail.comAchieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional SecuritiesJune 30, 2025 | globenewswire.comAchieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation - MorningstarJune 28, 2025 | morningstar.comMAchieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two ...June 28, 2025 | morningstar.comMAchieve Life Sciences Submits New Drug Application for Cytisinicline to Treat Nicotine Dependence in Adults - NasdaqJune 28, 2025 | nasdaq.comAchieve Life Sciences Shares Fall on $3 Underwritten Offering PriceJune 27, 2025 | marketwatch.comAchieve Life Sciences partners with Omnicom for product launchJune 27, 2025 | msn.comAchieve Life Sciences Teams With Omnicon on Nicotine Dependence TreatmentJune 27, 2025 | marketwatch.comAchieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking CessationJune 27, 2025 | finance.yahoo.comAchieve Life Sciences stock falls after pricing capital raise of $45M via securities offeringJune 27, 2025 | msn.comAchieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public OfferingJune 26, 2025 | globenewswire.comAchieve Life Sciences Announces Proposed Underwritten Public OfferingJune 26, 2025 | globenewswire.comAchieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two DecadesJune 26, 2025 | globenewswire.comAchieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving Average - Time to Sell?June 25, 2025 | marketbeat.comACHV Achieve Life Sciences, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comachieve life sciences holds annual meeting with key votesJune 7, 2025 | investing.comAchieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving Average - What's Next?June 5, 2025 | marketbeat.comAchieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies RiskJune 3, 2025 | seekingalpha.comAchieve Life Sciences to Present at the Jefferies Global Healthcare ConferenceMay 28, 2025 | globenewswire.comAchieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine IntakeMay 20, 2025 | globenewswire.comShay Capital LLC Sells 425,000 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV)May 19, 2025 | marketbeat.comEarnings call transcript: Achieve Life Sciences Q1 2025 targets nicotine dependence marketMay 14, 2025 | investing.comAchieve Life Sciences, Inc. Confirms NDA Submission for Cytisinicline to FDA in June 2025 and Reports Q1 2025 Financial ResultsMay 14, 2025 | nasdaq.comACHV: Kicking Butts to Achieve June NDA FilingMay 14, 2025 | finance.yahoo.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2025 Earnings Call TranscriptMay 14, 2025 | msn.comAchieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...May 14, 2025 | uk.finance.yahoo.comAchieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline ProgramMay 13, 2025 | globenewswire.comRaymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV)May 11, 2025 | marketbeat.comAchieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025May 6, 2025 | globenewswire.comAchieve Life Sciences (ACHV) Expected to Announce Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comAchieve Life Sciences Reports Positive Results from ORCA-3 Trial of Cytisinicline for Smoking CessationApril 23, 2025 | nasdaq.comAchieve Life Sciences announces publication of results from Phase 3 ORCA-3 trialApril 22, 2025 | finance.yahoo.comAchieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal MedicineApril 21, 2025 | globenewswire.comRaymond James Financial Inc. Invests $554,000 in Achieve Life Sciences, Inc. (NASDAQ:ACHV)April 9, 2025 | marketbeat.comJonesTrading Keeps Their Buy Rating on Achieve Life Sciences (ACHV)April 2, 2025 | markets.businessinsider.comD-Wave Claims to Achieve ‘Quantum Supremacy’ — Some Researchers DisagreeMarch 30, 2025 | techrepublic.comTAchieve Life Sciences, Inc. (ACHV): A Bull Case TheoryMarch 20, 2025 | insidermonkey.comInsider Buying: Achieve Life Sciences, Inc. (NASDAQ:ACHV) CFO Purchases 10,000 Shares of StockMarch 20, 2025 | marketbeat.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) CFO Purchases $28,900.00 in StockMarch 20, 2025 | insidertrades.com Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address ACHV Media Mentions By Week ACHV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACHV News Sentiment▼0.350.75▲Average Medical News Sentiment ACHV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACHV Articles This Week▼73▲ACHV Articles Average Week Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VSTM News EBS News XOMA News VNDA News CBIO News CDXS News AGEN News SGMO News IRWD News DOMH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACHV) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achieve Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access